- Article
Integrated Analysis of Key Differentially Expressed Genes Identifies DBN1 as a Predictive Marker of Response to Endocrine Therapy in Luminal Breast Cancer
- Lutfi H. Alfarsi,
- Rokaya El Ansari,
- Brendah K. Masisi,
- Ruth Parks,
- Omar J Mohammed,
- Ian O. Ellis,
- Emad A. Rakha and
- Andrew R. Green
Endocrine therapy is the mainstay of adjuvant treatment for patients with luminal breast cancer. Despite ongoing advances in endocrine therapy to date, a proportion of patients ultimately develop endocrine resistance, resulting in failure of therapy...